Q3 2021 Talis Biomedical Corp Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Talis Biomedical Third Quarter 2021 Earnings Conference Call. (Operator Instructions) I would now like to turn the conference over to your host, Emily Faucette, SVP, Corporate Communications and Investor Relations. Thank you. Please go ahead.
Good afternoon, and thank you for participating in Talis' third quarter conference call. Joining me today are Kim Popovits, our Interim Chief Executive Officer; Roger Moody, our Chief Financial Officer; Doug Liu, our Chief Operating Officer; and Rob Kelley, our Chief Commercial Officer. Earlier today, the company released its financial results and business progress for the quarter ended September 30, 2021. A copy of that press release can be accessed on the Investors page of our website at talisbio.com.
Before we get started, I would like to remind you that management will make statements during this call that are forward-looking statements within the meaning of the federal
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |